142 related articles for article (PubMed ID: 8790342)
1. Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.
Kirby SL; Cook DN; Walton W; Smithies O
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9402-7. PubMed ID: 8790342
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation.
Kirby S; Walton W; Smithies O
Blood; 2000 Jun; 95(12):3710-5. PubMed ID: 10845901
[TBL] [Abstract][Full Text] [Related]
3. Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor.
Urbinati F; Lotti F; Facchini G; Montanari M; Ferrari G; Mavilio F; Grande A
Hum Gene Ther; 2005 May; 16(5):594-608. PubMed ID: 15916484
[TBL] [Abstract][Full Text] [Related]
4. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.
Dubart A; Feger F; Lacout C; Goncalves F; Vainchenker W; Dumenil D
Mol Cell Biol; 1994 Jul; 14(7):4834-42. PubMed ID: 8007982
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent stem cells constitutively expressing a normal erythropoietin receptor give rise to normal hematopoiesis in lethally irradiated recipient mice.
Lacout C; Dubart A; Vainchenker W; Duménil D
Exp Hematol; 1996 Jan; 24(1):18-25. PubMed ID: 8536787
[TBL] [Abstract][Full Text] [Related]
6. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
7. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
8. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
Pharr PN; Hankins D; Hofbauer A; Lodish HF; Longmore GD
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):938-42. PubMed ID: 7679218
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
10. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
13. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo.
Huang X; Pierce LJ; Chen GL; Chang KT; Spangrude GJ; Prchal JT
Blood Cells Mol Dis; 2010 Jan; 44(1):1-6. PubMed ID: 19836979
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
18. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of erythropoietin receptor transgenes.
Kirby SL
Cytokines Cell Mol Ther; 1999 Jun; 5(2):97-104. PubMed ID: 10515682
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of murine multipotential stem cell colony (CFU-GEMM) growth to interleukin-3, erythropoietin, and hemin.
Monette FC; Sigounas G
Exp Hematol; 1987 Aug; 15(7):729-34. PubMed ID: 3497049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
